ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
FutureTech II Acquisition Corporation

FutureTech II Acquisition Corporation (FTII)

11.02
0.00
(0.00%)
Closed July 18 4:00PM
11.02
0.00
( 0.00% )
Pre Market: 7:00AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
11.02
Bid
10.90
Ask
11.15
Volume
-
0.00 Day's Range 0.00
10.69 52 Week Range 12.00
Market Cap
Previous Close
11.02
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
23,207
Shares Outstanding
2,954,510
Dividend Yield
-
PE Ratio
11.18
Earnings Per Share (EPS)
0.99
Revenue
-
Net Profit
2.91M

About FutureTech II Acquisition Corporation

FutureTech II Acquisition Corp is a blank check company. FutureTech II Acquisition Corp is a blank check company.

Sector
Blank Checks
Industry
Blank Checks
Headquarters
Wilmington, Delaware, USA
Founded
1970
FutureTech II Acquisition Corporation is listed in the Blank Checks sector of the NASDAQ with ticker FTII. The last closing price for FutureTech II Acquisition was $11.02. Over the last year, FutureTech II Acquisition shares have traded in a share price range of $ 10.69 to $ 12.00.

FutureTech II Acquisition currently has 2,954,510 shares outstanding. The market capitalization of FutureTech II Acquisition is $32.56 million. FutureTech II Acquisition has a price to earnings ratio (PE ratio) of 11.18.

FTII Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.12-1.0771992818711.1411.1411.0211811.02CS
4-0.05-0.45167118337911.0711.1411.0111711.0302672CS
12-0.09-0.81008100810111.111211.012320711.11927687CS
260.10.91575091575110.921210.882646411.0607553CS
520.322.9906542056110.71210.693000910.90615688CS
1561.0710.75376884429.9512.129.953747810.49395864CS
2601.0710.75376884429.9512.129.953747810.49395864CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AUGXAugmedix Inc
$ 2.28
(148.80%)
1.46M
HUBCWHub Cyber Security Ltd
$ 0.0345
(94.92%)
62
SERVServe Robotics Inc
$ 4.51
(71.48%)
5.69M
SXTP60 Degrees Pharmaceuticals Inc
$ 0.3885
(57.93%)
12.2M
NVOSNovo Integrated Sciences Inc
$ 0.777
(29.01%)
1.36M
KITTNauticus Robotics Inc
$ 0.1043
(-19.08%)
1.13M
SPWRSunPower Corporation
$ 1.24
(-17.88%)
687.32k
MTEMMolecular Templates Inc
$ 1.21
(-15.38%)
1
GDTCCytoMed Therapeutics Ltd
$ 1.97
(-13.98%)
247
SCHLScholastic Corporation
$ 32.39
(-11.41%)
187
SXTP60 Degrees Pharmaceuticals Inc
$ 0.3885
(57.93%)
12.2M
SGDSafe and Green Development Corporation
$ 0.408
(10.33%)
6.58M
SERVServe Robotics Inc
$ 4.51
(71.48%)
5.69M
SQQQProShares UltraPro Short QQQ
$ 8.19
(-0.49%)
3.42M
CRWDCrowdStrike Holdings Inc
$ 307.90
(-10.25%)
2.86M

Discussion

View Full Feed
LetGoodTimesRoll LetGoodTimesRoll 4 minutes ago
Goooood EM $RNVA morning!
Why are the saviors still messaging about a stock that RETAIL CAN'T BUY????????
RNVA
SCAMBUSTERKING SCAMBUSTERKING 4 minutes ago
What excuse down Brown come up with to do nothing with HPIL again this time? I assume it will be the lawsuits again, that he has avoided completely to ensure he cannot get a signed document from the judge for control. That would take away all his excuses.
HPIL
bunda bunda 4 minutes ago
lol
ILUS
TradeRewards TradeRewards 5 minutes ago
GEGP methodiccally doing the filings and no pump , just taking care of business. Confirmed in latest ANNUAL REPORT filing, GEGP is invloved in the "Distribution of orthopedic products, through Devon Orthopedic Implants llc. There is no Legal proceedings listed either.
Orthopedics is the mo
GEGP
TrendTrade2016 TrendTrade2016 5 minutes ago
AMIX...GAPPING UP ONCE AGAIN...2.29 MAGNET COME TO PAPA!!!
AMIX
The ELTP King The ELTP King 6 minutes ago
Still down.

Must have been a big check - possibly 8 figures.

Every possible FDA drug website search link has been down all morning for hours and hours.

Big pharma paid off the FDA so we can't see our Tentative Approval for Generic OxyContin which is due t
ELTP
hope4patients hope4patients 6 minutes ago
“Astonishing” clinical trial results published in peer-reviewed JAMA.

https://braintumourresearch.org/en-us/blogs/research-campaigning-news/astonishing-results-for-brain-tumour-vaccine-trial
NWBO
Big Hook Big Hook 6 minutes ago
I think that this company is introducing a technology that threatens or will disrupt all the crypto exchanges. That’s why all the threats.
Destructive technologies in the context of cryptocurrency refer to innovations that significantly alter or disrupt the existing landscape of financial sy
NSAV
bunda bunda 7 minutes ago
ask you mother f
IGPK
dshade dshade 7 minutes ago
Many feel the judge will make the decision on the 31st. However, there have not been any recent filings hinting at the end of the case.
XRPUSD
MightyX MightyX 7 minutes ago
Haven’t heard anything in while by traders regarding live-stream-events.
TPTW
pos_stock_hoarder pos_stock_hoarder 8 minutes ago
My plan: "Get your mower running.
Head out on the front yard."

Watching out for dung heaps
that may be blocking my way!
Nemesis18 Nemesis18 8 minutes ago
Ok then. Where do you suppose NWBO's SP should be now without the alleged market manipulation, based solely off one raggedy arsed , cut n paste P3 clinical trial.
Which was carried out by materially vested interests, which carries on to this very day ?

My only comfort is that
NWBO
scortech scortech 9 minutes ago
Even buys @ 2's there's quite a bit of risk.
CGAC
BIOCHEMUP BIOCHEMUP 9 minutes ago
Chart is shaping up again.
EMGE
FeMike FeMike 9 minutes ago
Statical Significant 2 words you and the other fudsters cannot dispute.
Statical
cannot dispute.

Eh......I think I can.
NWBO
Mark Mark 9 minutes ago
$LODE needs a .18 break and hold
LODE
Monksdream Monksdream 10 minutes ago
After 9:30 we will know
Mark Mark 11 minutes ago
$TCJH .46
TCJH
jbog jbog 11 minutes ago
Pfizer’s blockbuster drug tafamidis for the treatment of the rare heart disease transthyretin amyloid cardiomyopathy (ATTR-CM) needs at least a 96% discount off its list price to be considered cost-effective under common benchmarks.

Specifically, the ICER report suggests that tafamidi
Mark Mark 11 minutes ago
$LODE .17 break
LODE
AlchemicalCosmonaut95 AlchemicalCosmonaut95 12 minutes ago
eqe

Your Recent History

Delayed Upgrade Clock